Snowden Capital Advisors LLC Evotec Se Transaction History
Snowden Capital Advisors LLC
- $3.5 Billion
- Q3 2025
A detailed history of Snowden Capital Advisors LLC transactions in Evotec Se stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 29,053 shares of EVO stock, worth $87,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,053
Previous 29,053
-0.0%
Holding current value
$87,740
Previous $122,000
13.93%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EVO
# of Institutions
37Shares Held
4.06MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.43MShares$4.32 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT1.2MShares$3.62 Million1.96% of portfolio
-
Morgan Stanley New York, NY315KShares$951,0340.0% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA300KShares$906,8360.0% of portfolio
-
Pitcairn CO Jenkintown, PA162KShares$488,5420.05% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.07B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...